Sri Lanka Ministers Discuss Capping Drug Prices
This article was originally published in PharmAsia News
Sri Lanka officials are holding discussions about ways to control the prices of drugs in the wake of recent efforts to charge more for drugs.
You may also be interested in...
NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.